Literature DB >> 30093571

Evaluation of the airway microbiome in nontuberculous mycobacteria disease.

Imran Sulaiman1, Benjamin G Wu1, Yonghua Li1, Adrienne S Scott1, Patrick Malecha1, Benjamin Scaglione1, Jing Wang1, Ashwin Basavaraj1, Samuel Chung1, Katrina Bantis1, Joseph Carpenito1, Jose C Clemente2,3, Nan Shen2, Jamie Bessich1, Samaan Rafeq1, Gaetene Michaud1, Jessica Donington1, Charissa Naidoo4, Grant Theron4, Gail Schattner1, Suzette Garofano1, Rany Condos1, David Kamelhar1, Doreen Addrizzo-Harris1, Leopoldo N Segal1,5.   

Abstract

Aspiration is associated with nontuberculous mycobacterial (NTM) pulmonary disease and airway dysbiosis is associated with increased inflammation. We examined whether NTM disease was associated with a distinct airway microbiota and immune profile.297 oral wash and induced sputum samples were collected from 106 participants with respiratory symptoms and imaging abnormalities compatible with NTM. Lower airway samples were obtained in 20 participants undergoing bronchoscopy. 16S rRNA gene and nested mycobacteriome sequencing approaches characterised microbiota composition. In addition, inflammatory profiles of lower airway samples were examined.The prevalence of NTM+ cultures was 58%. Few changes were noted in microbiota characteristics or composition in oral wash and sputum samples among groups. Among NTM+ samples, 27% of the lower airway samples were enriched with Mycobacterium A mycobacteriome approach identified Mycobacterium in a greater percentage of samples, including some nonpathogenic strains. In NTM+ lower airway samples, taxa identified as oral commensals were associated with increased inflammatory biomarkers.The 16S rRNA gene sequencing approach is not sensitive in identifying NTM among airway samples that are culture-positive. However, associations between lower airway inflammation and microbiota signatures suggest a potential role for these microbes in the inflammatory process in NTM disease.
Copyright ©ERS 2018.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30093571     DOI: 10.1183/13993003.00810-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  23 in total

Review 1.  Perspectives in lung microbiome research.

Authors:  Imran Sulaiman; Sheeja Schuster; Leopoldo N Segal
Journal:  Curr Opin Microbiol       Date:  2020-07-02       Impact factor: 7.934

Review 2.  Methods in Lung Microbiome Research.

Authors:  Sharon M Carney; Jose C Clemente; Michael J Cox; Robert P Dickson; Yvonne J Huang; Georgios D Kitsios; Kirsten M Kloepfer; Janice M Leung; Tricia D LeVan; Philip L Molyneaux; Bethany B Moore; David N O'Dwyer; Leopoldo N Segal; Stavros Garantziotis
Journal:  Am J Respir Cell Mol Biol       Date:  2020-03       Impact factor: 6.914

3.  Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome.

Authors:  Imran Sulaiman; Matthew Chung; Luis Angel; Jun-Chieh J Tsay; Benjamin G Wu; Stephen T Yeung; Kelsey Krolikowski; Yonghua Li; Ralf Duerr; Rosemary Schluger; Sara A Thannickal; Akiko Koide; Samaan Rafeq; Clea Barnett; Radu Postelnicu; Chang Wang; Stephanie Banakis; Lizzette Pérez-Pérez; Guomiao Shen; George Jour; Peter Meyn; Joseph Carpenito; Xiuxiu Liu; Kun Ji; Destiny Collazo; Anthony Labarbiera; Nancy Amoroso; Shari Brosnahan; Vikramjit Mukherjee; David Kaufman; Jan Bakker; Anthony Lubinsky; Deepak Pradhan; Daniel H Sterman; Michael Weiden; Adriana Heguy; Laura Evans; Timothy M Uyeki; Jose C Clemente; Emmie de Wit; Ann Marie Schmidt; Bo Shopsin; Ludovic Desvignes; Chan Wang; Huilin Li; Bin Zhang; Christian V Forst; Shohei Koide; Kenneth A Stapleford; Kamal M Khanna; Elodie Ghedin; Leopoldo N Segal
Journal:  Nat Microbiol       Date:  2021-08-31       Impact factor: 17.745

4.  The lung microbiome in HIV-positive patients with active pulmonary tuberculosis.

Authors:  Veronica Ueckermann; Pedro Lebre; Janri Geldenhuys; Ebrahim Hoosien; Don Cowan; Luricke Janse van Rensburg; Marthie Ehlers
Journal:  Sci Rep       Date:  2022-05-28       Impact factor: 4.996

5.  Sputum Metabolites Associated with Nontuberculous Mycobacterial Infection in Cystic Fibrosis.

Authors:  Paul Breen; Madsen Zimbric; Kristopher Opron; Lindsay J Caverly
Journal:  mSphere       Date:  2022-04-28       Impact factor: 5.029

Review 6.  Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors.

Authors:  Roberta Rovito; Matteo Augello; Assaf Ben-Haim; Valeria Bono; Antonella d'Arminio Monforte; Giulia Marchetti
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

Review 7.  The lung microbiome: progress and promise.

Authors:  Samantha A Whiteside; John E McGinniss; Ronald G Collman
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 19.456

Review 8.  Host-microbe interactions in the pathogenesis and clinical course of sarcoidosis.

Authors:  Pleiades T Inaoka; Masato Shono; Mishio Kamada; J Luis Espinoza
Journal:  J Biomed Sci       Date:  2019-06-11       Impact factor: 8.410

Review 9.  Environmental Risk Factors for Sarcoidosis.

Authors:  Marc A Judson
Journal:  Front Immunol       Date:  2020-06-26       Impact factor: 7.561

10.  Could the Sputum Microbiota Be a Biomarker That Predicts Mortality after Acute Exacerbations of Chronic Obstructive Pulmonary Disease?

Authors:  Jun-Chieh J Tsay; Leopoldo N Segal
Journal:  Am J Respir Crit Care Med       Date:  2019-05-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.